Novartis and Par Antitrust Litigation

DiCello Levitt Secures $30M From Novartis To Settle Class Action Over Exforge Antitrust Claims. In October 2023, DiCello Levitt obtained final approval from the U.S. District Court for the Southern District of New York for a $30 million settlement with drugmaker Novartis to resolve a complex antitrust class action involving the hypertension medication Exforge. In … Continued

Class Action Takes Aim at Honda for Defective Auto Idle-Stop Feature

DiCello Levitt represents consumers in a group of class action lawsuits against Honda for selling and leasing certain Honda and Acura models that suffer from a dangerous defect that can cause their engines to stall while idling, putting the vehicles’ drivers and other motorists at risk of serious injury and death. The affected vehicles—which include … Continued

Ford Faces Class Action Lawsuit for Dangerous Tailgate Defect

DiCello Levitt represents proposed classes of Ford vehicle owners alleging that Ford knowingly advertised and sold certain truck models with a dangerous tailgate defect. The defect, which affects model year 2017–2021 Ford F-250, F-350, and F-450 Super Duty trucks with an electronic tailgate latch release switch, causes the trucks to spontaneously open—even while driving—posing serious … Continued

Hair Relaxers and Cancer

Hair relaxers are widely used. Studies suggest up to 90% of Black and Brown women have used hair relaxers and straighteners. Hair relaxers contain a wide range of endocrine-disrupting chemicals (EDCs) that interfere with the normal activity of the endocrine system. Exposure to hair relaxers usually begins in a woman’s formative childhood years and continues … Continued

Camp Lejeune Poisoning Injuries

For decades, over a million of our nation’s dedicated service members and their families were poisoned by contaminated drinking water at Marine Corps Base Camp Lejeune in North Carolina. Fortunately, recently enacted legislation empowers people to recover damages for their injuries. The Camp Lejeune Justice Act, a bipartisan bill signed into law in August 2022, … Continued

Paraquat Herbicide and Parkinson’s Disease

Since at least the mid‐1960s, experts have known that the herbicide paraquat—manufactured, marketed, and distributed by Chevron and Syngenta—is highly toxic to both plant and animal cells. Paraquat has been used since that time to kill broadleaf weeds and grasses before the planting or emergence of more than 100 field, fruit, vegetable, and plantation crops. … Continued

Tepezza and Hearing Loss

In January 2020, the U.S. Food and Drug Administration approved Tepezza, manufactured by Horizon Pharmaceuticals, to treat thyroid eye disease. TED inflames the eye muscles, eyelids, tear glands and fatty tissues behind the eye, which pushes the eyes forward causing bulging (known as proptosis) and may cause double vision. The signs and symptoms of TED … Continued

Fairlife Milk Products Marketing and Sales Practices Litigation

Animal Abuse and Deceptive Marketing Exposed, Resulting in $21M Recovery for Consumers In 2022, DiCello Levitt and its co-counsel secured a $21 million settlement in a consumer case against Coca-Cola, Fairlife, and other defendants associated with the Fairlife milk brand for their deceptive labeling and marketing of certain dairy products produced using milk from cows … Continued